1 Min Read
FRANKFURT, March 25 (Reuters) - Bayer AG : * Says ministry of health, labor and welfare (mhlw) in Japan has approved
stivarga * Says approval of stivarga is for treatment of patients with unresectable,
advanced/recurrent colorectal cancer
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.